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Fever o f unknown origin (FUO)
II. Diagnostic procedures in a prospective multicenter study of 167 patients
E l i s a b e t h  M. H. A. d e  Kl e i j n , M.D., H e n k  J. J. v a n  L i e r , Ph.D.,
Jos W. M. v a n  d e r  M e e r , M .D ., a n d  t h e  N e t h e r l a n d s  FUO S t u d y  G r o u p *
Introduction
The diagnostic workup of patients with fever of 
unknown origin (FUO) remains a challenge despite 
the variety of diagnostic methods currently 
available and many studies on the subject (1, 2, 7, 
9, 14, 17, 18, 21, 25, 28, 30, 32, 40, 41, 46, 51). FUO 
has been defined by Petersdorf and Beeson (40) as 
a febrile illness of more than 3 weeks’ duration, 
fever of 38.3 °C (101 °F) or higher on at least
3 occasions, and uncertain diagnosis after 1 week 
of inhospital diagnostic workup. Recently, this 
definition has been modernized by excluding 
immunocompromised patients like patients with 
neutropenia or acquired immunodeficiency 
syndrome (AIDS) (12).
Because a large number of diseases have been 
reported to cause FUO, it is difficult to construct
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algorithms covering the complete spectrum of 
FUO. Some attempts have been made in the past to 
outline diagnostic approaches (13, 16, 19, 26, 31, 38, 
50); although they are of value, it is impossible to 
extrapolate these algorithms to the individual 
patient with FUO. Many relevant questions remain 
when studying these algorithms. Should one 
perform all examinations mentioned in the staged 
protocol in patients without potentially diagnostic 
clues? What is the diagnostic yield of all these 
investigations under various circumstances? 
Which patients are at risk for a life-threatening 
disease? Is it possible to distinguish patients with 
benign fevers?
Based on data retrieved in a retrospective analysis 
of investigations performed in patients with FUO and 
a questionnaire on diagnostic techniques used in pa­
tients with FUO among Dutch internists, we devel­
oped a staged diagnostic protocol (9, 10). This 
protocol was used in a prospective study on FUO per­
formed during a 2-year period in all university hospi­
tals in the Netherlands, reported elsewhere in this 
journal (11). In this study, all investigations, the indi­
cations for these investigations, and the results were 
registered prospectively to recover their utility under 
various conditions.
Methods
In all 8 university hospitals in the Netherlands, all immuno­
competent patients fulfilling criteria for FUO according to Pe­
tersdorf and Beeson (40) were enrolled in this study. By 
reviewing records of all patients with fever and by checking the 
records of all patients in whom blood cultures were ordered on 
internal medicine wards, we tried to prevent unintended selec­
tion bias.
After informed consent, patients were included in our FUO 
protocol, which consisted of a standardized coded history and a 
standardized t horough physical examination. A number of addi­
tional investigations (Table 1) had to be performed in the first 
week of examination if an explanatory diagnosis was not estab­
lished. Much weight was given to the presence or absence of po­
tentially diagnostic clues (PDCs), defined as all localizing signs, 
symptoms, and abnormalities potentially pointing toward a diag­
nosis, and the use of these PDCs in the diagnostic process. PDCs
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TABLE 1. Diagnostic protocol
Obligatory investigations performed in all patients
Sedimentation rate; hemoglobin; mean cellular volume; platelet 
count; leukocyte count and differential count; serum urea nitro­
gen; creatinine; sodium; potassium; protein; protein fractions; 
alkaline phosphatase; aminotransferase; lactate dehydrogenase; 
creatine phosphokinase; ant.inuclear antibodies; rheumatoid 
factors; urinary analysis; feces for occult blood; blood cultures 
aerobic and anaerobic (n = 3); tuberculin test; urine, feces, and 
sputum culture when indicated; chest X-ray; ultrasonography of 
upper abdomen
Phase 1 diagnostic protocol in patients without PDCs (n = 
5) or with misleading PDCs only (n = 38)
Pulse/rectal temperature measurement by observer, fundoscopy 
by an ophthalmologist; calcium, phosphate, urate, amylase, and 
TSII/T4; immunoelectrophoresis of serum and urine; CRP; ACE; 
ANCA; anti-dsDNA; ASO; cryoglobulin; C3, C4, CH50; serology for 
Cytomegalovirus, Epstein-Barr virus, Mycoplasma, Brucella, 
Toxoplasma, Borrelia, Coxiella, Treponema, Yersinia; blood 
cultures incubating >  1 week; blood cultures, gastric fluid, mine 
cultures for tuberculosis; stools for worms, eggs, cysts; bone mar­
row puncture and culture for Mycobacteria, BmceUa, Yersin ia; 
In-lll-IgG scintigraphy; X-Ray of sinus and teeth; ultrasonogra­
phy of pehis
Phase 2 diagnostic protocol in patients without PDCs
(Performed when Phase 1 did not reveal PDCs or diagnosis) 
Hepatitis B serology; anergy tests; repeated chest X-ray; IgD in 
serum; liver biopsy and culture for Mycobacteria and other bac­
teria and fungi; crista biopsy and culture for Mycobacteria, Bru­
cella, and common bacteria; echocardiography; CT of abdomen 
and chest; X-Ray colon; temporal artery biopsy in patients over 
55 years
Abbreviations: TSH = thyroid-stimulating hormone; T4 = thy­
roxine; CRP = C-reactive peptide; ACE = angiotensin-converting 
enzyme; ANCA = antineutrophil cytoplasmic autoantibodies; ds- 
DNA = double-stranded deoxyribonucleic acid; ASO = antistrep­
tolysin O test; C = complement; CH50 = total hemolytic comple­
ment; In-lll-IgG = indium-ill-labeled polyclonal human 
immunoglobulin G; CT = computed tomography; PDCs = poten­
tially diagnostic clues.
derived from history, physical examination, and additional in­
vestigations had to be registered in the protocol form. Based on 
these PDCs a differential diagnosis had to be made by the at­
tending physician and registered in the protocol form. Based on 
this differential diagnosis, appropriate investigations were or­
dered to exclude or confirm these diagnoses in patients with 
PDCs. The indication to perform such investigations, and the en­
tity thus searched for, had to be registered also. In the absence 
of PDCs and in patients with only misleading PDCs, patients un­
derwent a staged standardized diagnostic protocol (see Table 1). 
Some tests were done as screening procedures in the absence of 
specific PDCs, before referral to the university hospital, or as a 
violation of the protocol by the attending physician. These were 
coded and studied also. Misleading PDCs are PDCs eventually 
not leading to the diagnosis. Helpful PDCs are PDCs eventually 
leading to the diagnosis.
Patients did not have to remain admitted; after inclusion, all in­
vestigations of the protocol could be performed on an outpatient 
basis. The clinical condition of the patient was the major reason 
for a longer stay in the hospital.
The standardized diagnostic protocol ended 1) when a definite 
diagnosis was made, 2) when PDCs appeared during the diagnos­
tic process, 3) when empiric treatment was started, or 4) when 
fever subsided. The final diagnosis was established by the attend­
ing physician and the first author. Diagnoses were established by 
serology, culture and histology preferably, but sometimes by ex­
clusion of other diseases or response to therapy and disease 
course.
Follow-up was performed by analysis of the records of the pa­
tients and by telephone calls with attending physicians and indi­
vidual patients; the last follow-up was performed in March 1996 for 
all patients with uncertain or no diagnosis.
In this study, periodic fever was defined as at least 2 episodes 
of fever, with intervals of at least 48 hours without fever.
Results of investigations were coded as normal or abnormal. 
Abnormal tests were subdivided as true positive (directly con­
tributing to the diagnosis), false positive (misleading), or equiv­
ocal (abnormal but not providing any convincing evidence or 
not leading to the cause of FUO). Normal tests were coded as 
true negative or false negative. Because a gold standard for di­
agnostic accuracy was not available for many investigations, 
specificity and sensitivity could only be calculated assuming 
that negative results were true negative when further investiga­
tion or the final diagnosis did not contradict these results. The 
indications for the investigations were registered and coded 
also.
Most investigations were performed in each university hospital 
by the locally standard applied method, because the scale of this 
study did not allow us to centralize these measurements and in­
vestigations. However, all immunoblots for Yersinia enterocolit- 
ica were performed by the Department of Medical Microbiology, 
University Hospital Nijmegen (22, 24,48). Interpretation of the im- 
munoblot was as follows:
IgA negative and IgG positive for at least 2- bands: infection in 
the past that was considered equivocal.
IgA positive for at least 1 band and IgG positive for at least 2 
bands: recent or persistent infection; this was considered a posi­
tive test.
IgA positive for 1 band and IgG positive for 1 band or IgA and 
IgG weakly positive for 1 or more bands: infection in past or be­
ginning infection, repeat necessary; when unchanged this result 
was considered equivocal.
All other microbiologic serology was considered positive only 
when a fourfold elevation of IgG titer was present. When IgM was 
present but no fourfold elevation could be demonstrated, the test 
was considered equivocal.
Statistical analysis: Comparisons between groups were per­
formed with the Fisher exact test (for the 2 x 2  tables) and the 
Mann-Whitney U test. P values of .05 or less were considered sig­
nificant, NS is an abbreviation for nonsignificant. Logistic re­
gression was applied to select variables that might predict 
whether a diagnosis would be made or not. Variables admitted 
in this analysis were most obligatory investigations (sedimenta­
tion rate, hemoglobin, mean cellular volume, platelet count, 
leukocyte and differential count, serum urea nitrogen, creati­
nine, sodium, potassium, protein, protein fractions, alkaline 
phosphatase, aminotransferase, lactate dehydrogenase, urinary 
analysis, antinuclear antibodies, blood cultures, Chest X-ray, 
and abdominal ultrasound), fever pattern, referral pattern, spe­
cific or nonspecific history and physical examination, age, sex, 
and the presence of night sweats. For the 8 university hospitals,
7 dummy variables were introduced. Logistic regression could 
be applied only to those patients who had “known” values for all
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admitted variables. In patients with known values for the se­
lected variables, but with missing values for 1 or more of the 
other admitted variables, it was verified whether the regression 
equation was valid. We calculated sensitivity and specificity 
with 95% confidence intervals.
Results
Of 167 patients meeting the criteria for FUO during 
the 2-year study period, a diagnosis could be made in 
only 117. In 43 (26%) patients, infections were found; 
in 21 (13%), neoplasms; in 40 (24%) patients, nonin- 
fectious inflammatory diseases (NIID) (11). A total of 
10,855 investigations in 167 patients was performed.
Utility of the screening diagnostic protocol
All data on history and physical examination were 
entered in a database. The most common PDCs 
(present in more than 10 patients) were the following 
(number of patients in parentheses): relevant dis­
eases in past (131), relevant operation in past (68), 
headache (62), myalgia (58), diarrhea (50), vertigo 
(48), arthralgia (48), changed bowel habits (42), nau­
sea (42), heart murmur (41), pulmonary abnormali­
ties (38), back pain (38), sore throat (37), abdominal 
complaints (37), dysuria (30), sensory dysfunction 
(28), arthritis (27), hepatomegaly (26), palpable 
breast abnormalities (22), contact with tuberculosis 
(21), visual complaints (21), tropical trip in recent 
past (21), goiter (20), splenomegaly (17), cold intol­
erance (17), neurologic abnormalities (17), insect 
bite (15), jaundice in past (15), dental intervention 
(15), hearing loss (15), heat intolerance (15), cervical 
lymphadenopathy (13), buccal aphthae (13), genital 
infection in past (12), generalized lymphadenopathy 
(11), and abnormal vaginal discharge (10). Other 
PDCs were found by various laboratory and imaging 
investigations in the first week of admission.
After 1 week of admission, PDCs were present in 
162 (97%) patients (Table 2, Figure 1). A diagnosis
TABLE 2. Potentially diagnostic clues* (PDCs) in 167










(n = 13) Total
Helpful PDCs only 53 53
Misleading and 48 48
helpful PDCs
Misleading 13 35 13 61
PDCs only
No PDCs 3 2 0 5
^Defined in Methods section.
was made in 114 of 162 (70%) patients with PDCs and 
in 3 of 5 (60%) patients without PDCs (Fisher exact 
test, NS). In 16 patients without PDCs or with only 
misleading PDCs, a diagnosis was made (Table 3). 
Not every patient without PDCs or with only mis­
leading PDCs underwent the complete first phase of 
the diagnostic protocol. Some investigations were 
not performed because new PDCs appeared or fever 
subsided. Forty-three patients completed the first 
phase; 15 of them also completed the second part. 
Exact data on the number of investigations per­
formed as a screening procedure in the absence of 
PDCs can be found in Tables 4 and 5.
Utility of investigations in the diagnostic process
Chemical investigations: The obligatory chemical 
tests (see Table 1) were done in more than 95% of all 
patients except for serum protein fractions (145 pa­
tients), fecal occult blood (109 patients), and crea­
tine phosphokinase (135 patients). None of the 
chemical investigations revealed the diagnosis, al­
though some contributed somewhat to the diagnosis: 
in 1 patient with hyponatremia, meningitis proved to 
be the cause of FUO. In 4 patients with elevated urea, 
further investigations revealed mixed cryoglobuline­
mia (n = 2), systemic lupus erythematosus (n = 1), 
and pyelonephritis with ureteral obstruction (n = 1) 
as cause of the fever. In 6 patients with abnormal 
liver chemistry, abnormalities in the liver explaining 
the FUO were found (localization of malignant lym­
phoma and Hodgkin lymphoma, cytomegalovirus (n 
= 2), hepatitis C, and liver metastasis of adenocarci­
noma). However, in 50% of our patients with FUO, 
nonspecific disturbances of liver chemistry were 
found. Fecal occult blood never was helpful in our 
patient group and was false positive in 10% of cases. 
In 1 patient, hypercalcemia led to the diagnosis of 
bone metastasis of breast cancer. Urate was elevated 
in 1 patient in whom gout presented as FUO. Creatine 
phosphokinase was elevated in 2 patients (with re­
lapse polymyositis and dermatomyositis with inter­
stitial lung fibrosis, respectively) and false positive in
1 patient, in whom a dental infection was the cause 
of FUO. Anemia, present in 127 patients, was normo- 
cytic in most patients. In 37 patients mean cellular 
volume (MCV) was abnormal; none of the 17 patients 
with microcytic anemia had gastrointestinal abnor­
malities responsible for the fever.
Immunologic serology (see Table 4): Antinuclear 
antibodies were helpful in establishing the diagno­
sis of systemic lupus erythematosus (n = 2), re­
lapse of mixed cryoglobulinemia, and relapse of 
polymyositis. The presence of rheumatoid factors 
was helpful in establishing diagnoses for relapse of
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Fig. 1. Diagnostic workup of 167 patients with fever of unknown origin. PDCs = potentially diagnostic clues.
TABLE 3. Diagnoses in 16 patients with no PDCs or with only misleading PDCs
Final Diagnosis* Decisive Diagnostic Procedure
No PDCs (n = 3)
Bacterial endocarditis Blood cultures not performed; 
without antibiotics in the referring hospital
Polyarteritis nodosa Fundoscopy+
Mixed cryoglobulinemia Cryoglobulin positive1
Misleading PDCs (n = 13)
Polyangiitis overlap syndrome CT of thorax (revealed aneurysms)1
Temporal arteritis (n = 3) Temporal biopsy1
Chronic yersiniosis (n = 2) Positive serology; reaction therapy1
Dental root infection Radiography of teethf, defervescence after 
extraction
Hodgkin disease Bone marrow biopsy1
Factitious fever (n = 2) Search for fraudulence
Drug fever (n = 3) Exclusion of other causes; after cessation of 
defervescence therapy
*N = 1 unless otherwise specified.
investigation performed in accordance with the diagnostic protocol.
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TP FP TP FP
ANA* 145(30/115) 2(7) 4 (13) 2(2) 17 (15)
Rfi: 124 (26/98) 1(4) 1(4) 1(1) 1(1)
IEF of serum* 105(16/89) 1(6) 3 (19) 2(2) 2(2)
ACE* 90 (14/76) 1(7) 3(21) 0 5(7)
ANCA* 98 (10/88) 1 (10) 2(20) 2(2) 6(7)
Anti-dsDNA 89 (16/73) 2(13) 0 0 2(3)
Cryoglobulin 68 (6/62) 3(50) 0 2(3) 0
Anti-ENA 62 (26/36) 2(8) 0 0 0
Complement profile 95 (13/82) 0 0 0 0
ASO test 78 (9/69) 0 0 0 0
Y. enteroeolitica immunoblot* 117(9/108) 0 1(10) 3(3) 11(10)
Blood cultures 167 (87/80) 6(7) 0 2(3) 2(3)
Fecal cultures 92 (37/55) 0 0 0 0
Sputum cultures 51 (38/13) 4(10) 3(8) 0 0
PPD skin test 83 (21/62) 2(10) 0 0 0
Abbreviations: ACE = angiotensin converting enzyme; ANA = antinuclear antibodies; ANCA = antineutrophil cytoplasmatic antibody; 
anti-dsDNA = antibody to double-stranded DNA; ASO = anti-streptolysin 0; ENA = extractable nuclear antigen; TP = true positive; FP 
= false positive; IEF = immunoelectrophoresis; PDCs = potentially diagnostic clues; Rf = rheumatoid factors; Y = Yersinia; PPD = pu­
rified protein derivative.
*See Results for detailed information.
polymyositis, relapse of mixed cryoglobulinemia, 
and vasculitis in rheumatoid arthritis. Immuno­
electrophoresis of the serum was helpful in est­
ablishing diagnoses for relapse of mixed 
cryoglobulinemia, Schnitzler disease, and gamma- 
heavy chain disease. In 1 patient with abnormalities 
on the chest X-ray, angiotensin converting enzyme 
(ACE) was helpful in finding sarcoidosis. In 1 
patient with histologically proven sarcoidosis, ACE 
was false negative. Antineutrophil cytoplasmatic 
antibody (ANCA) helped establish the diagnoses 
for polyarteritis nodosa (n = 1) and Wegener 
disease (n = 2). ANCA was false positive in patients 
with the following final diagnoses: relapse of 
cryoglobulinemia, ulcerative colitis, lung empyema 
with Actinomyces spp., hypersensitivity vasculitis, 
chronic pyelonephritis in ureter obstruction, 
sarcoidosis, and in 2 patients without diagnoses 
who recovered spontaneously without signs of 
vasculitis.
Endocrine investigations: In 1 patient who had di­
arrhea and weight loss, thyroid stimulating hormone 
(TSH) and thyroxine (T4) measurements proved the 
diagnosis of hyperthyroidism. In 4 patients, TSH was 
downregulated but hyperthyroidism was excluded 
by further testing. Diagnoses in these 4 patients were 
recurrent urinary tract infections, chronic 
pseudomonas infection of the lungs, hypersensitivity 
vasculitis, and no diagnosis, respectively. Plasma 
cortisol (n = 16), carcino-embryogenic antigen (n = 
11), and a-fetoprotein (n = 16) did not help in finding 
diagnoses.
Microbiologic serology (see Table 4): In all pa­
tients with cytomegalovirus infection, atypical lym­
phocytosis was present. The following serology did 
not help in establishing diagnoses in this study: Ep- 
stein-Barr virus (n = 92), Mycoplasma pneumoniae 
(n = 99), Brucella spp. (n = 73), Toxoplasma gondii 
(n = 85), Borrelia burgdorferi, (n = 72), Coxiella 
burnetii (n = 78), Chlamydia, psittaci (n = 62), hu­
man immunodeficiency vims (HIV) (n = 38), in­
fluenza vims (n = 44), Leptospira, spp. (n = 12), 
respiratory syncytial vims (n = 36), and rubella vims 
(n = 11). In 1 of 56 patients, serology for parain­
fluenza virus was positive. This patient also had right­
sided heart failure and no other cause for the fever 
could be found; she recovered without specific ther­
apy within 5 weeks. In 1 of 19 patients, a positive 
Widal test for Salmonella, typhi was helpful in estab­
lishing the diagnosis, although cultures (blood, 
stools, urine) remained negative after empirically 
started antibiotics before admission to the hospital. 
Because of the clinical picture and course we con­
cluded that she did have typhoid fever.
In 117 patients, serology for Yersinia enterocolit- 
ica was performed using the immunoblotting tech­
nique as described in the Methods section. Serology 
was negative in 57 patients, equivocal in 44 patients, 
and positive in 15 patients. The test was considered 
true positive in 3 of the 15 patients with positive serol­
ogy: after 6 weeks of treatment with ciprofloxacin, 
their fever resolved, serology became negative, and 
no other cause for the fever could be found. After a 
follow-up of more than 3 years, these 3 patients re­
mained afebrile. In 12 patients the test was consid­
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ered false positive; treatment of more than 6 weeks 
with doxycycline and ciprofloxacin had no effect on 
the fever, and, in most of the 12, other causes for fever 
were found: malignant lymphoma (n = 2), right ad­
nexitis, urinary tract infection, relapse of rheumatoid 
arthritis, mixed cryoglobulinemia, nonclassifiable 
granulomatous myositis, factitious fever, sarcoidosis, 
and no diagnosis (n = 3). Overall sensitivity and 
specificity were 100% and 89%, respectively (confi­
dence intervals: 0.29-1.0 and 0.82-0.94, respectively).
Culture techniques (see Table 4): Aerobic and 
anaerobic blood cultures, obligatory investigations in 
our diagnostic protocol, were performed in all pa­
tients. In 8 (5%) patients these cultures contributed 
more or less to establishing the diagnosis: endocardi­
tis in 2 patients, abscesses in 3 patients, an infected 
central venous device, Pseudomonas spp. bacteremia 
in pneumonia, and diverticulitis. In 19 patients false 
positive blood cultures were found growing coagu- 
lase-negative staphylococci (n = 10), Streptococcus 
viridans (n = 3), Mycobacterium kansasii, 
Corynebacterium spp., Propionibacterium spp., an 
anaerobic Gram-negative rod, an aerobic spomlating 
rod, and Enterobactei~ cloacae combined with Bacil­
lus spp. (1 patient each). Blood cultures from a patient 
with ischemic colitis as a later complication and stom­
ach cancer as cause of FUO grew Bacteroides fragilis; 
we consider these results equivocal.
Urinary cultures (n = 134) were helpful in estab­
lishing the diagnosis in 5 patients. None of the 69 pa­
tients with a normal urinary sediment turned out to 
have a urinary infection. In 5 patients the test was 
considered false positive. After treating the assumed 
urinary tract infection adequately, bacteriuria disap­
peared, whereas the fever remained unchanged. In 24 
patients bacteriuria was found with less than 105 mi- 
croorganisms/mL; there were no signs of a urinary 
tract infection in any of them.
Fecal cultures for Salmonella spp., Campylobac­
ter jejuni, Shigella spp., and Yersinia enterocolitica 
were performed in 92 patients; none of the cultures 
was positive. In 1 patient the clinical course com­
bined with a positive Widal test suggested salmonel­
losis as cause of the FUO; cultures probably 
remained negative because of empirically started an­
tibiotics before admission.
None of the cultures of blood, urine, and gastric 
fluid for Mycobactei'ium tuberculosis was positive, 
and none of the cultures for other microorganisms 
performed without PDCs in accordance with the di­
agnostic protocol contributed to the diagnosis.
Other cultures contributing to the diagnosis al­
ways were performed because PDCs were present 
for infection (that is, culture of liver biopsy in a pa­
tient with cryptococcal infection, cerebrospinal fluid 
in a patient with Spitz-Holter drain and hypona­
tremia, lymph node in a patient with tuberculous 
lymphoma, pleural fluid in a patient with actinomy­
cosis, central line tip in a patient with infected cen­
tral venous device, and pericardium biopsy in a 
patient with tuberculous pericarditis).
Imaging techniques (see Table 5): A chest X-ray 
helped to establish the following diagnoses in 6 pa­
tients without PDCs for chest diseases: Hodgkin dis­
ease, malignant lymphoma, recurrent pneumonia 
combined with urinary tract infection, disseminated 
cryptococcosis, systemic lupus erythematosus, and 
sarcoidosis. One patient with pleural empyema had a 
normal chest X-ray, but scintigraphic and computed 
tomography (CT) techniques revealed the diagnosis. 
Assuming all other chest X-rays to be true negative, 
we calculated overall sensitivity and specificity (see 
Table 5).
Upper abdominal ultrasonography was performed 
in only 158 of 167 patients because an abdominal CT 
had already been performed in 9 patients before in­
clusion or referral to the university hospital. Upper 
abdominal ultrasonography contributed to the fol­
lowing diagnoses: malignant lymphoma, liver ab­
scess and pelvic abscess (2 patients each), 
angioimmunoblastic lymphoma, gamma-heavy chain 
disease, sarcoidosis, right-sided heart failure, sys­
temic lupus erythematosus in a patient with enlarged 
kidneys and abnormal ultrasound reflections, liver 
metastasis (seen on second ultrasonography), 
chronic pyelonephritis in ureter obstruction, and tu­
berculous pericarditis. Abnormal findings were seen 
on ultrasonography in 68 patients, but in 12 (8%) pa­
tients the findings led to unnecessary investigations 
and thus were considered false positive. In 3 patients 
ultrasonography was considered false negative be­
cause abdominal CT revealed the diagnosis.
Abdominal CT was helpful in making the diagnosis 
in 2 patients without PDCs (that is, pericarditis due 
to vasculitis in rheumatoid arthritis and malignant 
lymphoma, respectively). In 14 patients abdominal 
CT was considered false positive because it led to un­
necessary investigations like laparoscopy, puncture 
of suspected lesions, or laparotomy. Abdominal 
causes for the fever were not found in any of the pa­
tients with a normal abdominal CT. Considering 
these CT to be true negative, we calculated overall 
sensitivity and specificity (see Table 5).
In 3 patients without PDCs, a chest CT enabled us 
to diagnose tuberculous pericarditis, malignant lym­
phoma, and dennatomyositis with interstitial lung fi­
brosis, respectively. In 1 patient, the chest CT was 
normal, but shortly thereafter an enlarged axillary 
lymph node became palpable, which turned out to be 
a lymph node metastasis of a previously treated lar­
ynx carcinoma.
Transthoracic echocardiography was useful in
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TABLE 5. Diagnostic utility of imaging techniques and histologic investigations
No. of Patients Patients Overall Overall
Investigation Patients with PDCs without PDCs Sensitivity Specificity
( + PDCs/-PDCs) TP FP TP FP %(CI) % (Cl)
Chest X-ray* 167 (51/116) 12' 4 6+ 2 95 (73-99) 96 (91-98)
Abdominal US* 158 (47/111) 7 5 6 7 81 (54-96) 92 (85-96)
Pelvic US 28 (9/19) 2 2 0 2 100 (16-100) 85 (65-96)
X-ray, sinuses 82 (19/63) 0 4 0 4 NC NC
X-ray, teeth 47 (6/41) 0 0 1 0 NC NC
Abdominal CT* 84 (51/34) 121 10 2t 4 100 (77-100) 80 (69-89)
Chest CT* 45 (30/15) 12 4 3 1 94 (70-99) 83 (64-94)
Heart US* 66 (33/33) 61 3 W 2 86 (42-98) 92 (81-97)
X-ray, colon* 29 (16/13) 3 2 0 3 100 (30-100) 81(61-93)
X-ray, ileum* 24 (16/8) 0 1 0 0 NC NC
Inm IgG scan 58 (35/23) 9f 5 0+ 3 48 (24-71) 80 (63-91)
Ga-67 scan 27 (5/22) 1 1 1 9 100 (16-100) 60 (39-79)
Bone scan* 28(17/11) 4 6 0 6 80 (29-97) 48 (27-70)
BM aspiration* 74 (40/34) 1 2 0 0 14 (2-58) 97 (90-100)
Liver biopsy* 34 (25/9) 2 0 1 0 75 (20-96) 100(88- 100)
BM biopsy* 49 (23/26) 5 1 4 2 NC NC
Temporal biopsy 26 (7/19) 2 0 2 0 NC NC
Enteric biopsy 13 (7/6) 1 0 0 0 NC NC
Skin biopsy* 25 (23/2) 3 1 0 0 NC NC
Skin-muscle biopsy* 29 (17/12) 61 1 ot 0 NC NC
Colonic biopsy 11 ( 11/0) 1 0 0 0 NC NC
Abbreviations: BM = bone marrow; Cl = confidence interval; CT = computed tomography; FP = false positive; Ga-67 = Gallium-67; 
Inm IgG = Indium-111-labeled immunoglobulin G; NC = not calculated; PDCs = potentially diagnostic clues; TP = true positive; US = ul­
trasonography; X-ray = radiography.
*See Results for detailed information.
Statistically significant by the Fisher exact test.
finding the following diagnoses in 6 patients with 
PDCs for cardiac disease: endocarditis (n = 2), peri­
cardium infiltration in acute leukemia, mitral and tri­
cuspid valve disease in heart failure, pericarditis due 
to vasculitis in rheumatoid arthritis, and tuberculous 
pericarditis. In 1 patient with endocarditis proven at 
autopsy, echocardiography was negative several 
times.
X-ray of the colon helped to find the following di­
agnoses in 3 patients with PDCs: colonic polyp in 
Streptococcus bovis endocarditis, diverticulitis, and 
diverticulitis causing multiple hepatic abscesses.
X-ray series of the small bowel (n = 24) did not 
contribute to the diagnosis in this study. Abnormal 
pictures (nodular ileitis not consistent with Crohn 
disease) were found in 1 patient with positive 
Yersinia enterocolitica serology. Prolonged courses 
of antibiotics did not cure this patient, and he still 
suffers from periodic fever.
Imaging techniques that were helpful in finding the 
diagnosis (only in patients with PDCs) were the fol­
lowing: 2 of 19 brain CTs, showing infarction in 2 pa­
tients with endocarditis; CT of thoracic spine 
showing lesions of Hodgkin disease; intravenous 
pyelography showing obstruction of the left ureter in 
pelvic abscess; 1 of 10 mammograms showing a le­
sion that proved to be cancer; 2 of 13 Doppler ultra­
sound studies showing venous thrombosis and a 
lesion that turned out to be T-cell lymphoma.
Scintigraphic techniques (see Table 5): Results of 
the indium-Ill-labeled polyclonal immunoglobulin 
G (Inu lIgG) scintigraphy are described extensively 
elsewhere (8) (see Table 5). Other scintigraphic 
methods like In11 ^ leukocyte scintigraphy (per­
formed in 16 patients) and Technetium-99m-leuko- 
cyte scintigraphy (8 patients) were all performed in 
patients without PDCs for local inflammation or in­
fection and did not help establish a diagnosis. In 6 pa­
tients, positive scans were found but after extensive 
further investigations, no local inflammation could 
be confirmed. An infection was found only in 2 of 17 
patients with negative scans.
Gallium-67 scintigraphy was performed in 27 pa­
tients (see Table 5). A localized inflammation was not 
found in any of the 15 patients with negative scans. 
Considering these scans to be true negative, we cal­
culated overall sensitivity and specificity.
A bone scintigraphy helped to find the following di­
agnoses in 4 patients with PDCs for local inflamma­
tion: Hodgkin disease (n = 2), Still disease (showing 
arthritis), and bone metastasis of breast cancer. In 1 
patient with endocarditis and osteomyelitis caused 
by Staphylococcus aureus, bone scintigraphy was 
false negative.
Histologic investigations (see Table 5): Bone mar­
row aspiration helped to establish the diagnosis in 1 
patient with acute monocytic leukemia. This patient
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had ail extreme left shift in the peripheral blood, and
2 previous bone marrow aspirations were not con­
clusive. In 2 patients, bone marrow cytology was 
false positive. In the first patient, myelodysplastic 
syndrome was suspected in the first aspiration, but 
after spontaneous recovery, this could not be con­
firmed. He has been afebrile for more than 3 years 
now, and a diagnosis has never been established. In 
the other patient, myelodysplastic syndrome was 
suspected but at autopsy, culture-negative endo­
carditis was found. In 6 patients bone marrow aspi­
ration did not yield specific abnormalities, whereas 
bone marrow biopsy was helpful in establishing the 
diagnosis; considering these tests as false negative, 
and the remaining tests as true negative, we calcu­
lated overall sensitivity and specificity (see Table 5).
Liver biopsy was helpful in finding the diagnosis in
3 (9%) patients. In 1 patient without PDCs for liver 
disease, liver biopsy helped establish the diagnosis of 
granulomatous hepatitis. No underlying disease was 
found, and after therapy with corticosteroids, his 
condition improved in several months, without re­
currence for 4 years now. In 1 patient with disturbed 
liver chemistry only, liver biopsy was helpful in find­
ing the diagnosis of disseminated cryptococcal in­
fection. In a third patient with abnormal liver 
chemistry, ultrasonography of the upper abdomen 
was normal in the first week of admission. A second 
ultrasonography showed a large lesion in the liver, a 
biopsy of which revealed adenocarcinoma. In 22 pa­
tients, liver biopsy showed nonspecific abnormalities 
only. In 1 patient a blind liver biopsy was false nega­
tive, showing nonspecific abnormalities only, 
whereas histology of biopsies at laparoscopy showed 
granulomatous hepatitis.
Bone marrow biopsy aided in the diagnosis in 9 
(18%) patients. In 4 patients without PDCs for blood 
disorders or lymphadenopathy, the diagnoses ma­
lignant lymphoma and Hodgkin disease (2 patients 
each) were found with the help of bone marrow 
biopsy. In 3 patients with peripheral blood smear 
abnormalities (leukopenia in 2, extreme left shift in 
1), biopsy established the following diagnoses: 
Hodgkin disease, acute myelofibrosis, and acute 
monocytic leukemia. Bone marrow biopsy in 1 pa­
tient with hot spots on a bone scintigraphy estab­
lished the diagnosis of metastasis of an 
adenocarcinoma of the breast. The fifth patient had 
generalized lymphadenopathy, and bone marrow 
biopsy pointed to the diagnosis of angioim- 
munoblastic lymphoma, which was confirmed by a 
third lymph node biopsy. In 3 patients the results 
were false positive. In 1 patient, bone marrow 
biopsy suggested myelodysplastic syndrome, but a 
repeated biopsy could not confirm this. Eventually, 
temporal arteritis proved to be the cause of the 
fever. In 1 patient the bone biopsy showed features
of malignant lymphoma, but the patient recovered 
spontaneously and a second bone biopsy was com­
pletely normal. She has been afebrile for 3 years 
now. In a third patient, Hodgkin disease was sus­
pected from bone marrow biopsy, but after revision 
the diagnosis was sarcoidosis. Since in 3 of 37 pa­
tients with normal bone marrow biopsies, disorders 
that could have involved the bone marrow (an- 
gioimmunoblastic lymphoma, Hodgkin disease, and 
gamma-heavy chain disease) were found eventually 
by other means, the possibility exists that the re­
sults were false negative. It therefore seems haz­
ardous to give figures for sensitivity and specificity.
Bronchoalveolar lavage (BAL) was performed in 
21 patients for cytologic and microbiologic investi­
gations, 19 of whom had abnormal chest radi­
ographs. In 1 patient only, BAL established the 
diagnosis. This patient had culture-negative pleural 
empyema; histologic examination of the BAL fluid 
showed Actinomyces colonies. After a 6-week treat­
ment with penicillin, fever and symptoms subsided.
In 25 patients a skin biopsy was performed, in­
cluding 2 patients without skin lesions. In 3 patients 
with skin lesions, the procedure helped to find the 
following diagnoses: urticarial vasculitis, hypersensi­
tivity vasculitis, and erythema nodosum in the con­
text, of tuberculous axillary lymphoma. In 15 
patients, nonspecific abnormalities were found. In 1 
patient, skin biopsy suggested septic embolism. 
Treatment with penicillin had no effect. Because of 
complaints of arthritis and urethritis with conjunc­
tivitis and moderate response to salicylate, the pre­
sumed diagnosis was Reiter disease. The patient’s 
complaints disappeared completely after 8 months, 
and 3 years later no other cause for the fever has 
been found.
Biopsy of skin and muscle was performed in 17 pa­
tients with PDCs (skin diseases or abnormal elec­
tromyography) (see Table 5). In 1 patient with 
abnormal electromyography, histologic examination 
of the biopsy material revealed lymphocytic arteritis; 
the patient recovered spontaneously after 1 month 
without a diagnosis being made. He has been free of 
disease for more than 4.5 years now.
hi 24 patients, enlarged lymph nodes were removed 
for histologic and microbiologic investigations; this 
procedure helped to establish the diagnosis in 12 (50%) 
of them. No pathologic lymph nodes were present at 
physical examination upon admission in 5 of these 12 
patients, but in 11 of these 12 patients, generalized lym­
phadenopathy was demonstrated after extensive ultra­
sonographic and radiographic investigations. Lymph 
node biopsies were not helpful in establishing the di­
agnosis if lymphadenopathy was confined to the cervi­
cal or inguinal region (n = 8). In the case of generalized 
lymphadenopathy, biopsy was helpful in 11 of 14 pa­
tients (Fisher exact test, p = .001).
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In 3 of 4 patients with urine abnormalities, renal 
biopsy was helpful (Wegener disease, systemic 
lupus erythematosus, mixed cryoglobulinemia with 
glomerulonephritis).
A lumbar puncture was performed in 11 patients; 
in 2 as a screening procedure without any PDCs, im­
plying a violation of the diagnostic protocol. In 2 
(18%) patients this technique was helpful in finding 
the diagnosis; both patients had severe headache but 
no signs of meningitis. In these patients a sterile 
mononuclear infiltrate of the cerebrospinal fluid was 
found, and in 1 patient biopsy of the meninges was 
negative. The presumable diagnosis of Mollaret 
meningitis was established in both by exclusion of 
other diseases.
In 5 patients, splenectomy was part of the diagnostic 
workup before referral because splenomegaly was 
found; it led to the diagnosis in 2 patients. In the first 
patient, there was a discrepancy between the 
histology of the bone marrow biopsy and that of 
the spleen; the diagnosis remained uncertain 
until generalized lymphadenopathy developed 
and lymph node histology was done which 
showed angioimmunoblastic lymphadenopathy 
with dysproteinemia (AILD). In the second patient, 
bone marrow biopsy was suspect for Hodgkin 
disease but proof could be found only by spleen 
histology.
Other successful histologic investigations per­
formed because PDCs were present were articular 
puncture (n = 3) proving pseudogout in 1 patient, 
gastroscopy (n = 11) with gastric biopsy proving 1 
case of stomach cancer, pleural puncture (n = 13) 
pointing to systemic lupus erythematosus in 1 pa­
tient, and pericardial puncture (n = 1) in 1 patient 
proving tuberculous pericarditis.
Predictors of likelihood of reaching a diagnosis
Univariate analysis (Table 6): For all parameters 
and PDCs, the value of predicting the likelihood of 
reaching a diagnosis was established with help of uni­
variate analysis. Parameters that were significantly dif­
ferent between patients with a final diagnosis and 
patients without a diagnosis are listed in Table 6. Of all 
specific and nonspecific PDCs in the history and phys­
ical examination, only night sweats reached statistical 
significance. There was also no significant difference 
between the 2 groups concerning sex, presence of 
PDCs, use of the screening diagnostic protocol, age, 
duration of fever, referral pattern, and fever pattern 
(continuous versus discontinuous).
Logistic regression of prediction of possible di­
agnosis (Table 7): All values of the variables admit­
ted in logistic regression were known in 92 patients. 
After stepwise selection, 3 variables remained in the
logistic regression model: serum protein elec­
trophoresis (1 = normal, 2 = abnormal), periodic 
fever (1 = 1 period, 2 = more than 1 period) and he­
moglobin (Hb) (1 = normal, 2 = abnormal). In an ad­
ditional 53 patients the values of serum protein 
electrophoresis, periodic fever, and Hb were known, 
while some of the other admitted variables had miss­
ing values. With the regression coefficients (1.83, 
-1.43, 1.21, respectively) and an intercept of -2.70, 
we estimated the probability of finding a diagnosis.
Discussion
In this study, we prospectively evaluated the util­
ity of diagnostic techniques used in patients with 
FUO. In a retrospective study on FUO (9), we found 
that the use of diagnostic techniques was abundant, 
whereas in many cases the exact indication for the in­
vestigation could not be retrieved. The present study 
allows us to draw conclusions on the overall diag­
nostic value of many of these techniques, and by 
prospective registration of PDCs, estimate the 
screening diagnostic value of many of these tech­
niques.
The merit of chemical investigations is mainly to 
direct the physician to the possible location of dis­
ease, making a more selective search possible; only 
rarely do these investigations lead directly to the di­
agnosis. In this study, 50% of the patients were found 
to have nonspecific liver disturbances, but in only 6 
(4%) patients were specific liver diseases the cause of 
FUO. Thus, finding such disturbances is relatively 
meaningless. This is in agreement with data from ear-
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TABLE 6. Significantly different param eters in patients
with and without diagnosis*
No Diagnosis Diagnosis
Parameter (n = 50) (n = 117)
(No. of Patients) No. (%) No. (%)
Elevated ESR (164) 38 (76) 104 (90)
Abnormal Hb (167) 29 (58) 98 (84)
Abnormal sodium (164) 5 (10) 32 (28)
Lowered serum 9(19) 41 (39)
protein (151)
Abnormal protein 29 (63) 92 (93)
electrophoresis (145)
Abnormal ASAT (167) 10 (20) 45 (39)
Proteinuria (151) 6(14) 36 (33)
Night sweats (140) 40 (91) 70 (75)
Periodic fever (167) 28 (56) 28 (24)
Hospitalization < 21 26 (52) 34 (20)
days
Median hospitalization 19 (7-83) 34 (7-295)
in days (range)
Abbreviations: ESR = erythocyte sedimentation rate; Hb = he 
nioglobin; ASAT = aspartate aminotransferase.
*Using univariate analysis.
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TABLE 7. Classification of patients with known values of variables and those with some missing values












Nonrial 1 Normal 1 1 0 1 .25
Abnormal 3 2 2 2 .53
> 1 Normal 0 6 1 2 .07
Abnormal 0 2 0 1 .21
Abnormal 1 Normal 5 3 4 2 .68
Abnormal 38 6 21 2 .88
> 1 Normal________ 2________ 3________ 4________ 2_______ .33
Abnormal 13 7 5 4 .63
Abbreviations: EPD = estimated probability of diagnosis from logistic regression in patients with known value.
lier studies (23, 34) showing that abnormal liver tests 
in FUO are not predictive of a diagnostic liver biopsy.
The diagnostic yield of immunologic serology is 
also relatively low. Although antinuclear antibodies, 
rheumatoid factors, ACE, ANCA, antibody to dsDNA, 
and extractable nuclear antigen sometimes con­
tributed to the diagnosis, these tests are more often 
false positive and are of little use without PDCs 
pointing to specific immunologic disorders. Mixed 
cryoglobulinemia turned out to be a rather common 
cause of FUO, even in patients without specific PDCs 
and underlying disorders. Thus, this investigation 
seems worthwhile even in patients without PDCs.
In the literature, atypical subacute thyroiditis (42) 
and other masked thyroid diseases (44, 45) appear as 
a cause of FUO. Most of the patients reported did not 
have overt thyrotoxicosis but had some features of 
thyroid disease such as weight loss despite a good ap­
petite and frequent bowel movements. This finding 
was confirmed in our series. It can be concluded that 
the diagnostic yield of thyroid testing without the 
presence of any PDCs for thyroid disease is very low.
In all published series on FUO, infections are the 
most common cause of FUO. The screening value of 
microbiologic serology in patients without PDCs has 
never been studied before in patients with FUO. In 
our series of patients without PDCs for infection, the 
diagnostic yield of these tests appeal's to be very low. 
Such investigations should not be used as screening 
procedures early in the diagnostic process for pa­
tients without PDCs for specific infections. Serology 
for cytomegalovirus infection appeal's to be helpful 
only in patients with PDCs for cytomegalovirus in­
fection (for example, atypical lymphocytosis), as 
previously described (32, 40). A relatively new tech­
nique used in this series is Western blot serology for 
Yei'sinia enterocolitica, Although occasionally help­
ful, its low specificity seems to limit the use in this 
group of patients.
The diagnostic yield of imaging procedures is often 
difficult to establish because the yield of these tech­
niques depends on other investigations performed al­
ready. In our study we tried to avoid this problem by 
including a chest radiography and abdominal ultra­
sonography in the first obligatory part of the diag­
nostic protocol and by dividing the protocol into 2 
stages. When there were pulmonary complaints or 
abnormalities at physical examination, the chest ra­
diography was very useful, but even in patients with­
out pulmonary disorders this simple technique was 
of use sometimes.
We included abdominal ultrasonography as an 
obligatory test in all included patients with FUO. Ex­
trapolation of data presented by comparative studies 
on abdominal ultrasound and CT in the patient with 
FUO is hazardous. Only 1 study (33) tried to minimize 
systemic bias as to the type of examination per­
formed last (the diagnostic yield of techniques is de­
pendent on the techniques already used), by 
scheduling patients so that each examination was 
performed first in roughly one-third of patients. In 
this study it was found that the 2 modalities have a 
similar ability to detect local inflammation. We had 
several reasons for choosing ultrasonography in­
stead of CT as an obligatory test: the relatively low 
cost, no radiation burden, little discomfort for the pa­
tient. In a substantial proportion of patients, upper 
abdominal ultrasonography was useful, and we feel 
this test should remain obligatory in the diagnostic 
workup of all patients with FUO. However, we 
should keep in mind that in a considerable propor­
tion of patients, upper abdominal ultrasonography 
was false positive and led to unnecessary investiga­
tions. Ultrasonography of the pelvis was not useful in 
patients without PDCs and led to unnecessary inves­
tigations in some patients. When negative in a patient 
with prolonged fever, the abdominal ultrasonogra­
phy has to be supplemented by abdominal CT in a 
later phase, which has a very high sensitivity. One has 
to be careful, however, not to overinteipret CT data 
because of the relatively low specificity. Unneces­
sary and invasive diagnostic procedures may be ini­
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tiated. Sensitivity and specificity of abdominal and 
chest CT appear to be similar; the latter has not been 
studied previously in patients with FUO.
Not much is known about the value of echocardio­
graphy in patients with FUO. Our results show that in 
patients with more than 3 weeks of fever, the tech­
nique was useful only in patients with PDCs for car­
diac abnormalities (that is, heart murmur, friction 
rub, or chest pain) and that it is not an appropriate 
technique to use early in the diagnostic process when 
such PDCs are absent.
Scintigraphic techniques were useful only in pa­
tients with PDCs for local inflammation or infection, 
as we have extensively discussed elsewhere (8). 
These techniques were useless as screening proce­
dures in our population of patients.
Radiologic evaluation of the gastrointestinal tract 
can be valuable if performed in the proper setting. In 
our study it never was useful as a screening proce­
dure, and we believe it should not be used as a 
screening procedure in patients without abdominal 
PDCs. Even in the presence of microcytic anemia, ab­
normalities of the gastrointestinal tract were not re­
sponsible for the FUO in our series.
We used X-rays of the sinuses as a screening pro­
cedure, as advised by others (16, 38, 39, 43). The di­
agnostic yield was very low, and, in many patients, 
false positive findings led to unnecessary investiga­
tions.
Bone marrow aspiration was of little use in the ab­
sence of PDCs for a bone marrow disorder. Thus, as 
a screening procedure this technique is of little use, 
and anemia alone is certainly not a reason to perform 
tliis investigation in patients with FUO.
The diagnostic yield of liver biopsy in patients with 
FUO has been studied extensively in the past. It is 
likely that selected groups of patients with PDCs for 
liver abnormalities were studied. In our study, liver 
biopsy was part of the second stage of the screening 
diagnostic protocol and was performed in 9 patients 
without PDCs for liver abnormalities, yielding 1 case 
of unexplained granulomatous hepatitis. We are 
aware of the discussion whether the descriptive di­
agnosis “granulomatous hepatitis” is a real diagnosis 
or should be put in the “no diagnosis” group (30). In 
order not to conceal this interesting group of patients 
even though the causal relationship between granu­
lomatous hepatitis and FUO is not clear, and, in most 
cases, the entity is secondary to a vast variety of dis­
eases (15, 20), we did not classify this condition in 
the “no diagnosis” group. We feel that liver biopsy in 
the absence of PDCs may be of some use in a later 
stage of the diagnostic workup.
In our population of patients with FUO, bone mar­
row biopsy had a relatively high diagnostic yield 
when performed in a later stage of the diagnostic 
process, even in the absence of PDCs. We are not
aware of other studies investigating the screening 
value of this technique.
Because temporal arteritis is an important cause of 
FUO in patients older than 50 years (30), we included 
temporal biopsy as a screening procedure in a later 
stage of the diagnostic protocol in patients older than 
55 years. Despite this rigorous search, temporal ar­
teritis was found in only 2 patients without PDCs and 
in 2 patients with typical complaints. Thus, in our 
study the diagnostic yield was not as high as in that 
of Knockaert and colleagues (30), who found tempo­
ral arteritis in 15% of the cases. In a late stage of 
workup and before starting empirical cortico­
steroids, it is justified to perform such a biopsy.
The role of the BAL in patients with FUO has not 
been elucidated. Although in most patients undergo­
ing BAL, chest radiography was abnormal, the diag­
nostic yield was very low. Selection of patients was 
probably the most important reason for this low util­
ity. The technique is used early in the diagnostic 
process of lung abnormalities, and patients in whom 
the procedure is useful will probably not classify as 
FUO.
In this study the screening value of small-intestinal 
biopsy was nil. It was also of little value in patients 
with abdominal complaints, probably because Crohn 
and Whipple disease and coeliac disease were not 
found in our series. We feel it should not be used as 
a screening procedure early in the diagnostic 
process.
Skin and skin-muscle biopsy had a diagnostic yield 
of 35% in our series, only when performed in patients 
with skin abnormalities and/or abnormal elec­
tromyography. Other studies on polyarteritis nodosa 
(PAN), systemic necrotizing vasculitis, and FUO (6, 
35, 49) also showed that skin-muscle biopsy is useful 
only in suspect skin or muscle areas.
In our population, if lymphadenopathy was con­
fined to the cervical or inguinal region (with negative 
X-ray of chest and abdominal ultrasound), lymph 
node biopsy was not helpful in establishing the diag­
nosis, in contrast to patients with generalized lym­
phadenopathy in whom it had a high yield.
Unlike in the study of Knockaert (30), blood cul­
tures were still helpful in establishing the diagnosis 
of endocarditis in 2 of our patients. In both patients 
blood cultures became positive after the patient 
stopped taking empirically stalled antibiotics, an as­
pect already emphasized by others (3, 25, 40).
It can be concluded from our series that cultures 
of urine, of sputum, and from other specific sites 
were useful only in patients with PDCs pointing to 
those sites. By performing screening cultures the risk 
of confusion with false-positive cultures is greater 
than the diagnostic yield.
Tuberculin skin testing was positive in 2 patients 
who turned out to have active tuberculosis; in a third
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patient with tuberculosis, a skin test was not per­
formed. In none of the other patients was a positive 
purified protein derivative (PPD) found, reflecting 
the low prevalence of tuberculosis in our country. In 
other series tuberculin testing did not perform so 
well because of the high rates of false negative tests 
in patients with active tuberculosis (up to 25%) (37) 
and high rates of positive tests without active disease 
in certain subgroups like elderly patients (5) and im­
migrants from developing countries (47).
The importance of PDCs has been emphasized in 
many reviews of FUO. The attending physician is ad­
vised to observe the Sutton Law: “to go where the 
money is” (4, 13, 27, 36, 50). The value of PDCs has 
not been evaluated systematically before. Two retro­
spective studies showed significantly lower chances 
of reaching a diagnosis when no PDCs were present 
(9, 51). This was not confirmed in the present study, 
in which we prospectively registered and used PDCs 
and found that the presence of PDCs does not in­
crease the likelihood of reaching a diagnosis. Be­
cause of the low percentage of patients without 
PDCs, these findings have to be interpreted carefully: 
we have no doubt that the search for PDCs remains 
the most important tool for the doctor to find the 
cause of FUO, but our study demonstrates that many 
of these PDCs are misleading and do not lead to a di­
agnosis. In univariate and logistic regression analysis 
of patients with and without a diagnosis, we found 
significant differences only for periodic or intermit­
tent fever, erythrocyte sedimentation rate (ESR), and 
hemoglobin, in accordance with Knockaert (29). The 
chances of finding a diagnosis is significantly higher 
in patients with continuous fever, high ESR, and low 
hemoglobin. It is interesting to see that other PDCs 
and parameters, such as hepatosplenomegaly, age, 
duration of fever, the existence of PDCs, and the use 
of the screening diagnostic protocol, did not influ­
ence the likelihood of finding a diagnosis.
It was surprising that our diagnostic protocol was 
of use in 26% of the patients to whom it was applied. 
Indeed, this figure seems high, but when we look at 
the investigations that really are of diagnostic value 
when used as screening procedure, only a few should 
be used that way: temporal artery biopsy in patients 
older than 55 years, fundoscopy, sophisticated serol­
ogy for Yersinia enterocolitica, serum for cryoglob­
ulinemia in an early stage, and bone biopsy and 
abdominal and chest CT in a later stage of the diag­
nostic process. This means that the screening diag­
nostic protocol can be limited rigorously in the 
absence of PDCs.
Ordering investigations as screening procedures in 
the hope (mostly vain) that something abnormal will 
come up has many disadvantages, like possible ad­
verse reactions or complications, loss of faith of the 
patient, staggering costs of testing, and—perhaps
most important—a soporific effect on the doctor s di­
agnostic mental activities. Repeating a thorough his­
tory-taking, physical examination, and obligatory 
investigations and waiting for PDCs to appeal' proba­
bly is better than ordering more screening investiga­
tions in the hope that something abnormal will come 
up. Supportive treatment with nonsteroidal anti-in­
flammatory drugs (NSAIDs) can be helpful at this 
stage. Only rarely do patients deteriorate while using 
NSAIDs without presenting new PDCs. In these rare 
patients, further diagnostic workup should be per­
formed or a therapeutic trial with, for example, antibi­
otics, steroids, or antituberculous agents started.
Summary
From January 1992 until January 1994, we used a 
standardized diagnostic protocol for the 167 im­
munocompetent patients with fever of unknown ori­
gin (FUO) admitted on the internal medicine wards 
in all 8 university hospitals in the Netherlands. This 
protocol consisted of a standardized coded history 
and standardized physical examination for all 167 pa­
tients. A number of additional obligatory investiga­
tions had to be performed in the first week of 
admission for all patients, and all potentially diag­
nostic clues (PDCs) thus retrieved had to be regis­
tered. In the presence of PDCs, specific 
investigations had to be performed based on the dif­
ferential diagnosis. In the absence of PDCs or in the 
presence of only misleading PDCs, patients under­
went a screening 2-staged diagnostic protocol.
In 162 (97%) patients, PDCs were present after 1 
week of admission. In 61 patients these PDCs were 
all misleading. The likelihood of reaching a diagnosis 
in patients with PDCs was not significantly higher 
than that in patients without PDCs, probably because 
of the high proportion of misleading PDCs. The like­
lihood of establishing a diagnosis was significantly 
lower ( < 10%) only for patients with recurrent fever, 
normal erythrocyte sedimentation rate (ESR), and 
normal hemoglobin. All other PDCs were not signifi­
cantly different in patients with a diagnosis com­
pared with patients without a diagnosis.
The screening 2-staged diagnostic protocol proved 
useful in 10 of 43 patients in whom it was used. The 
screening value of immunologic and microbiologic 
serology and endocrine investigations was nil; these 
investigations probably should be performed only 
when PDCs for the disease searched for are present. 
Scintigraphic techniques, echocardiography, and 
other imaging procedures were never helpful in our 
population in the absence of PDCs. Many patients 
with FUO had nonspecific anemia and disturbed liver 
chemistry. In the presence of these findings alone, 
without other more specific PDCs, the likelihood of
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reaching a diagnosis with help of bone marrow aspi­
ration was nil, and with help of liver biopsy, it was 
low. Enteric biopsy was never helpful. If lyrn- 
phadenopathy was confined to the cervical or in­
guinal region (with negative chest X-ray and 
abdominal ultrasound), lymph node biopsy was not 
helpful, in contrast to patients having generalized 
lymphadenopathy, in whom the technique had a yield 
of 79%.
As shown in this study, the search for PDCs re­
mains an important tool for establishing the diagno­
sis in patients with FUO, although in many cases 
these PDCs appear to be misleading. Directed diag­
nostic workup—using the PDCs retrieved by re­
peated, meticulous history taking and physical 
examination—remains the most efficient and intel­
lectually satisfactory way to solve the problem of 
FUO in the individual patient. A standard protocol in 
patients with FUO in whom the obligatory investiga­
tions, as used by us, do not lead to the diagnosis can 
be limited to the tests that proved to be of some use 
as screening procedure: temporal biopsy in patients 
older than 55 years; fundoscopy; serology (Western 
blot) for Yersinia enterocolitica; serum for cryo­
globulin at an early stage of the diagnostic process; 
and bone biopsy, liver biopsy, abdominal computed 
tomography (CT), and chest CT at a later stage. Re­
peating a thorough history-taking, physical examina­
tion, and obligatory investigations and waiting for 
PDCs to appear probably is better than ordering 
more screening investigations in the hope that some­
thing abnormal will come up. Supportive treatment 
with nonsteroidal anti-inflammatory drugs (NSAIDs) 
can be helpful at this stage. Only rarely do patients 
deteriorate while using NSAIDs without presenting 
new PDCs. In these rare patients, further diagnostic 
workup should be performed or a therapeutic trial 
with, for example, antibiotics, steroids, or antituber- 
culous agents started.
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